• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性疼痛中与阿片类药物相关的风险认知:患者性别和既往滥用行为的影响

Opioid-related risk perceptions in chronic pain: influence of patient gender and previous misuse behaviors.

作者信息

Grant Alexis D, Miller Megan M, Anastas Tracy M, Quinn Patrick, Lok Benjamin, Hirsh Adam T

机构信息

Department of Psychology, Indiana University-Purdue University Indianapolis, Indianapolis, IN, United States.

Department of Applied Health Science, School of Public Health, Indiana University Bloomington, Bloomington, IN, United States.

出版信息

Pain. 2022 Apr 1;163(4):711-718. doi: 10.1097/j.pain.0000000000002412.

DOI:10.1097/j.pain.0000000000002412
PMID:34285152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8761212/
Abstract

Little is known about the factors that influence providers' perceptions of patient risk for aberrant opioid use. Patient gender may interact with previous opioid misuse to influence these perceptions. We asked 131 physicians to view videos and vignettes for 8 virtual patients with chronic pain. Gender (male/female) and previous prescription opioid misuse (present/absent) varied across patients; the vignettes were otherwise balanced on demographic and clinical characteristics. For each patient, providers assessed 4 risk domains: opioid-related adverse events, opioid misuse or abuse, opioid addiction, and opioid diversion. Results indicated a significant gender-by-misuse interaction for risk of opioid misuse orabuse. When previous misuse behaviors were absent, providers rated men at higher risk; there was no gender difference when previous misuse behaviors were present. A significant gender-by-misuse interaction was found for risk of opioid-related adverse events. Providers perceived men to be at higher risk when previous misuse behaviors were absent; there was no gender difference when previous misuse behaviors were present. A significant gender-by-misuse interaction was found for risk of opioid addiction. Providers rated women at higher risk when previous misuse behaviors were present and men at higher risk when previous misuse behaviors were absent. There were significant main effects of gender and misuse for risk of opioid diversion. Providers rated men and those with previous misuse behaviors at higher risk. These results demonstrate that patient gender and previous opioid misuse have unique and interactive effects on provider perceptions of prescription opioid-related risks. Studies are needed to identify the mechanisms underlying these effects, such as gender-based stereotypes about risk-taking and drug abuse.

摘要

关于影响医疗服务提供者对患者异常使用阿片类药物风险认知的因素,我们所知甚少。患者性别可能与先前的阿片类药物滥用情况相互作用,从而影响这些认知。我们让131名医生观看8名患有慢性疼痛的虚拟患者的视频和病例描述。患者的性别(男/女)和先前是否有处方阿片类药物滥用情况(有/无)各不相同;病例描述在人口统计学和临床特征方面保持平衡。对于每名患者,医疗服务提供者评估了4个风险领域:阿片类药物相关不良事件、阿片类药物滥用或误用、阿片类药物成瘾以及阿片类药物转移。结果表明,在阿片类药物滥用或误用风险方面存在显著的性别与滥用情况的交互作用。当不存在先前的滥用行为时,医疗服务提供者认为男性风险更高;当存在先前的滥用行为时,不存在性别差异。在阿片类药物相关不良事件风险方面也发现了显著的性别与滥用情况的交互作用。当不存在先前的滥用行为时,医疗服务提供者认为男性风险更高;当存在先前的滥用行为时,不存在性别差异。在阿片类药物成瘾风险方面发现了显著的性别与滥用情况的交互作用。当存在先前的滥用行为时,医疗服务提供者认为女性风险更高;当不存在先前的滥用行为时,认为男性风险更高。在阿片类药物转移风险方面,性别和滥用情况存在显著的主效应。医疗服务提供者认为男性以及有先前滥用行为的人风险更高。这些结果表明,患者性别和先前的阿片类药物滥用情况对医疗服务提供者对处方阿片类药物相关风险的认知具有独特的交互作用。需要开展研究来确定这些影响背后的机制,比如基于性别的冒险和药物滥用刻板印象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/413f3cfacbb7/nihms-1724865-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/6249f14ea8bc/nihms-1724865-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/6c101049487e/nihms-1724865-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/220a50d257f4/nihms-1724865-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/44e5029ed682/nihms-1724865-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/413f3cfacbb7/nihms-1724865-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/6249f14ea8bc/nihms-1724865-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/6c101049487e/nihms-1724865-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/220a50d257f4/nihms-1724865-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/44e5029ed682/nihms-1724865-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72aa/8761212/413f3cfacbb7/nihms-1724865-f0005.jpg

相似文献

1
Opioid-related risk perceptions in chronic pain: influence of patient gender and previous misuse behaviors.慢性疼痛中与阿片类药物相关的风险认知:患者性别和既往滥用行为的影响
Pain. 2022 Apr 1;163(4):711-718. doi: 10.1097/j.pain.0000000000002412.
2
Patient race and opioid misuse history influence provider risk perceptions for future opioid-related problems.患者种族和阿片类药物滥用史影响提供者对未来与阿片类药物相关问题的风险认知。
Am Psychol. 2020 Sep;75(6):784-795. doi: 10.1037/amp0000636.
3
Identification of prescription opioid misuse and abuse behaviors and risk factors in chronic pain patients using the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ).使用处方阿片类药物误用与滥用问卷(POMAQ)识别慢性疼痛患者的处方阿片类药物误用和滥用行为及风险因素。
Curr Med Res Opin. 2023 Mar;39(3):441-450. doi: 10.1080/03007995.2023.2174343. Epub 2023 Feb 10.
4
Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.处方阿片类药物的滥用和误用:初级保健研究者评估与慢性疼痛患者中这些行为的实际程度之间的差距。
Postgrad Med. 2017 Jan;129(1):5-11. doi: 10.1080/00325481.2017.1245585. Epub 2016 Oct 26.
5
Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.慢性疼痛中的处方阿片类药物滥用:阿片类药物滥用预测因素及遏制阿片类药物滥用策略的最新综述:第1部分
Pain Physician. 2017 Feb;20(2S):S93-S109.
6
Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).慢性疼痛中的处方阿片类药物滥用:阿片类药物滥用预测因素及遏制阿片类药物滥用策略的最新综述(第2部分)
Pain Physician. 2017 Feb;20(2S):S111-S133.
7
Problematic Prescription Opioid Use in a Chronic Pain Treatment Facility: The Role of Emotional Processes.慢性疼痛治疗机构中存在问题的处方阿片类药物使用:情绪过程的作用。
Subst Use Misuse. 2019;54(3):495-505. doi: 10.1080/10826084.2018.1521426. Epub 2018 Oct 31.
8
Safe management of chronic pain in pregnancy in an era of opioid misuse and abuse.阿片类药物滥用时代妊娠期慢性疼痛的安全管理
J Obstet Gynecol Neonatal Nurs. 2014 Sep-Oct;43(5):554-567. doi: 10.1111/1552-6909.12487. Epub 2014 Aug 14.
9
Factors associated with prescription opioid misuse in adults aged 50 or older.与 50 岁及以上成年人处方阿片类药物滥用相关的因素。
Nurs Outlook. 2018 Mar-Apr;66(2):112-120. doi: 10.1016/j.outlook.2017.10.007. Epub 2017 Nov 29.
10
Chronic noncancer pain management in primary care: family medicine physicians' risk assessment of opioid misuse.基层医疗中的慢性非癌性疼痛管理:家庭医学医生对阿片类药物滥用的风险评估
Postgrad Med. 2015 Jan;127(1):22-6. doi: 10.1080/00325481.2015.993572. Epub 2014 Dec 25.

引用本文的文献

1
Efficacy and safety of 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1, 2-benzothiazin-3-carboxamide 1,1-dioxide, a rapid-acting meloxicam formulation, for analgesia after orthopaedic surgery under general anaesthesia: a randomized controlled trial.4-羟基-2-甲基-N-(5-甲基-2-噻唑基)-2H-1,2-苯并噻嗪-3-甲酰胺 1,1-二氧化物(一种快速起效的美洛昔康制剂)用于全身麻醉下骨科手术后镇痛的疗效和安全性:一项随机对照试验。
Inflammopharmacology. 2024 Dec;32(6):3799-3808. doi: 10.1007/s10787-024-01575-z. Epub 2024 Oct 14.
2
Preemptive QP001, a fast-acting meloxicam formulation, provides analgesia and reduces opioid consumption following abdominal surgery: a randomized controlled trial.快速起效美洛昔康 QP001 用于腹部手术后镇痛:一项随机对照试验
Inflammopharmacology. 2023 Oct;31(5):2401-2410. doi: 10.1007/s10787-023-01322-w. Epub 2023 Aug 30.